These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9123576)

  • 1. Suppression of the xenoantigen Gal alpha(1,3)Gal by N-acetylglucosaminyltransferase III (GnT-III) in transgenic mice.
    Tanemura M; Miyagawa S; Ihara Y; Nishikawa A; Suzuki M; Yamamura K; Matsuda H; Shirakura R; Taniguchi N
    Transplant Proc; 1997; 29(1-2):895-6. PubMed ID: 9123576
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of the major swine xenoantigen Gal alpha (1,3)Gal by transfection of N-acetylglucosaminyl transferase III (GnT-III) gene.
    Tanemura M; Miyagawa S; Ihara Y; Mikata S; Matsuda H; Shirakura R; Taniguchi N
    Transplant Proc; 1997; 29(1-2):891-2. PubMed ID: 9123573
    [No Abstract]   [Full Text] [Related]  

  • 3. Remodeling of the major mouse xenoantigen, Galalpha1-3Galbeta1-4GlcNAc-R, by N-acetylglucosaminyltransferase-III.
    Chung TW; Kim KS; Kang SK; Lee JW; Song EY; Chung TH; Yeom YI; Kim CH
    Mol Cells; 2003 Dec; 16(3):343-53. PubMed ID: 14744025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection.
    Tanemura M; Miyagawa S; Ihara Y; Matsuda H; Shirakura R; Taniguchi N
    Biochem Biophys Res Commun; 1997 Jun; 235(2):359-64. PubMed ID: 9199197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the Gal-alpha1,3-Gal epitope of mouse endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene.
    Chung TW; Kim KS; Kim CH
    Mol Cells; 2003 Dec; 16(3):368-76. PubMed ID: 14744028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc.
    Koyota S; Ikeda Y; Miyagawa S; Ihara H; Koma M; Honke K; Shirakura R; Taniguchi N
    J Biol Chem; 2001 Aug; 276(35):32867-74. PubMed ID: 11443114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal.
    Alvarado CG; Cotterell AH; Parker W; Logan JS; Platt JL
    Transplant Proc; 1996 Apr; 28(2):555. PubMed ID: 8623266
    [No Abstract]   [Full Text] [Related]  

  • 8. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig.
    Miyagawa S; Murakami H; Takahagi Y; Nakai R; Yamada M; Murase A; Koyota S; Koma M; Matsunami K; Fukuta D; Fujimura T; Shigehisa T; Okabe M; Nagashima H; Shirakura R; Taniguchi N
    J Biol Chem; 2001 Oct; 276(42):39310-9. PubMed ID: 11486004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys.
    Komoda H; Miyagawa S; Omori T; Takahagi Y; Murakami H; Shigehisa T; Ito T; Matsuda H; Shirakura R
    Xenotransplantation; 2005 May; 12(3):209-16. PubMed ID: 15807771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisecting GlcNAc structure is implicated in suppression of stroma-dependent haemopoiesis in transgenic mice expressing N-acetylglucosaminyltransferase III.
    Yoshimura M; Ihara Y; Nishiura T; Okajima Y; Ogawa M; Yoshida H; Suzuki M; Yamamura K; Kanakura Y; Matsuzawa Y; Taniguchi N
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):733-42. PubMed ID: 9560299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
    Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of various glycosyltransferases on the swine xenoantigen.
    Koma M; Miyagawa S; Honke K; Ikeda Y; Koyota S; Murase A; Tsuji S; Miyoshi S; Matsuda H; Shirakura R; Taniguchi N
    Transplant Proc; 2000 Aug; 32(5):855. PubMed ID: 10936241
    [No Abstract]   [Full Text] [Related]  

  • 13. Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I.
    Zhang W; Betel D; Schachter H
    Biochem J; 2002 Jan; 361(Pt 1):153-62. PubMed ID: 11742540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic pigs with human N-acetylglucosaminyltransferase III.
    Miyagawa S; Murakami H; Murase A; Nakai R; Koma M; Koyota S; Matsunami K; Takahagi Y; Fujimura T; Shigehisa T; Nagashima H; Shirakura R; Taniguchi N
    Transplant Proc; 2001; 33(1-2):742-3. PubMed ID: 11267048
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of the major xenoantigen gal alpha(1,3)gal in pigs and mice.
    McKenzie IF; Koulmanda M; Mandel T; Xing PX; Sandrin MS
    Transplant Proc; 1995 Feb; 27(1):247-8. PubMed ID: 7878987
    [No Abstract]   [Full Text] [Related]  

  • 16. High-level expression of the Neisseria meningitidis lgtA gene in Escherichia coli and characterization of the encoded N-acetylglucosaminyltransferase as a useful catalyst in the synthesis of GlcNAc beta 1-->3Gal and GalNAc beta 1-->3Gal linkages.
    Blixt O; van Die I; Norberg T; van den Eijnden DH
    Glycobiology; 1999 Oct; 9(10):1061-71. PubMed ID: 10521543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis.
    Shinzaki S; Ishii M; Fujii H; Iijima H; Wakamatsu K; Kawai S; Shiraishi E; Hiyama S; Inoue T; Hayashi Y; Kuwahara R; Takamatsu S; Kamada Y; Morii E; Tsujii M; Takehara T; Miyoshi E
    J Gastroenterol; 2016 Apr; 51(4):357-69. PubMed ID: 26349931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling.
    Wang Y; Chen S; Xu Z; Chen S; Yao W; Gao X
    Neuropharmacology; 2018 Mar; 131():190-199. PubMed ID: 29223528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin graft of double transgenic pigs of N-acetylglucosaminyltransferase III (GnT-III) and DAF (CD55) genes survived in cynomolgus monkey for 31 days.
    Fujita T; Miyagawa S; Ezoe K; Saito T; Sato N; Takahagi Y; Murakami H; Matsunami K; Shirakura R; Taniguchi N
    Transpl Immunol; 2004 Dec; 13(4):259-64. PubMed ID: 15589738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
    Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
    Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.